Literature DB >> 17697470

Thermal degradation of poly(3-hydroxybutyrate) and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) in nitrogen and oxygen studied by thermogravimetric-Fourier transform infrared spectroscopy.

Christian Vogel1, Shigeaki Morita, Harumi Sato, Isao Noda, Yukihiro Ozaki, Heinz W Siesler.   

Abstract

The thermal degradation behavior of poly(3-hydroxybutyrate) (PHB) and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (P(HB-co-HHx), HHx=12 mol%) has been studied under different environmental conditions by thermogravimetric analysis (TGA) Fourier transform infrared (FT-IR) spectroscopy. It is reported that at higher temperature (>400 degrees C) carbon dioxide and propene are formed from the decomposition product crotonic acid in a nitrogen atmosphere, whereas in an oxygen atmosphere propene oxidizes in a further step to carbon dioxide, carbon monoxide and hydrogen. It was also found that PHB and P(HB-co-HHx) have a similar thermal degradation mechanism. The analysis of the FT-IR-spectroscopic data was performed with 2D and perturbation-correlation moving-window 2D (PCMW2D) correlation spectroscopy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697470     DOI: 10.1366/000370207781393370

Source DB:  PubMed          Journal:  Appl Spectrosc        ISSN: 0003-7028            Impact factor:   2.388


  2 in total

1.  Isolation and optimization of extracellular PHB depolymerase producer Aeromonas caviae Kuk1-(34) for sustainable solid waste management of biodegradable polymers.

Authors:  Mohammad Amir; Naushin Bano; Abu Baker; Qamar Zia; Saeed Banawas; Mohd Rehan Zaheer; Mohammad Shariq; Md Sarfaraz Nawaz; Mohd Farhan Khan; Z R Azaz Ahmad Azad; Anamika Gupta; Danish Iqbal
Journal:  PLoS One       Date:  2022-04-14       Impact factor: 3.240

2.  Poly(3-Hydroxybutyrate)-Based Nanoparticles for Sorafenib and Doxorubicin Anticancer Drug Delivery.

Authors:  György Babos; Joanna Rydz; Michal Kawalec; Magdalena Klim; Andrea Fodor-Kardos; László Trif; Tivadar Feczkó
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.